Anutosh Ranjan Saha

Statistics

Publications

Citations

3.3K

H-Index

Active since

1984

Affiliations

Bristol-Myers Squibb (United States)(Current)

Otsuka (United States)

Bristol-Myers Squibb (Germany)

University of Florida

University of South Florida

Anutosh Ranjan Saha is an author at Bristol-Myers Squibb (United States) specializing in antipsychotic therapy, antipsychotic pharmacology, and psychopharmacology.

Publications per year

1984–2003

Publications

Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder

John M. Kane, William H. Carson, Anutosh Ranjan Saha et al. · The Journal of Clinical Psychiatry · 2002 · 625 citations

Medicine, Pharmacotherapy, Psychiatry +17

Aripiprazole, an Antipsychotic With a Novel Mechanism of Action, and Risperidone vs Placebo in Patients With Schizophrenia and Schizoaffective Disorder

Steven G. Potkin, Anutosh Ranjan Saha, Mary J. Kujawa et al. · Archives of General Psychiatry · 2003 · 593 citations

Medicine, Pharmacology, Pharmacotherapy +16

A Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of Aripiprazole in Patients With Acute Bipolar Mania

Paul E. Keck, Ronald N. Marcus, Stavros Tourkodimitris et al. · American Journal of Psychiatry · 2003 · 503 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

Stephen R. Marder, Robert D. McQuade, Elyse Stock et al. · Schizophrenia Research · 2003 · 469 citations

Medicine, Pharmacology, Psychiatry +10

Aripiprazole for the Prevention of Relapse in Stabilized Patients With Chronic Schizophrenia

Teresa A. Pigott, William H. Carson, Anutosh Ranjan Saha et al. · The Journal of Clinical Psychiatry · 2003 · 311 citations

Medicine, Pharmacotherapy, Psychiatry +17

1–5 of 10